Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
FTC sues OptumRx, rivals over insulin pricing
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
Insulin pricing targeted by FTC
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
The American Journal of Managed Care40m
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...
The Washington Post on MSN56m
FTC sues pharmacy insurance managers, alleging unfair drug prices
The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S. drug ...
In unusual rebuke of SoCal sheriff, medical examiner rules diabetic man’s jail death a homicide by neglect
According to autopsy findings requested by The San Diego Union-Tribune and released this week by the Medical Examiner’s ...
GoLocalProv51m
FTC Sues Prescription Drug Middlemen Including CVS for Artificially Inflating Insulin Drug Prices
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...